All Stories

  1. Challenges in inpatient diabetes care: A single-day snapshot or a shot at the heart of the problem?
  2. Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial
  3. Determinants of Maximal Oxygen Consumption in Cardiac Rehabilitation Patients: The Role of Sex
  4. N-terminal pro B-type natriuretic peptide increase after bariatric surgery is linked to decreased insulin resistance and is more pronounced in women
  5. Tracking Chronic Diseases via Mobile Health Applications: Which User Experience Aspects Are Key?
  6. A 10-step guide to standardising patient-reported outcomes data collection in healthcare: insights from the health outcomes observatory (H2O) project on overcoming implementation barriers
  7. Myo‐Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study
  8. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  9. Exploring the Influence of Sex and Gender on Cancer: A Comprehensive Analysis
  10. Cluster-Based Immunization Patterns in Diabetes Mellitus: Insights for Personalized Preventive Care
  11. 1H and 31P MRS Interleaved With High Time Resolution Reveals Closely Matching Creatine CH₂ and PCr Dynamics During Exercise
  12. Association of fetal FTO gene variants with maternal postload glucose levels in pregnancy
  13. Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy
  14. Konsensuspapier der Österreichischen Adipositasgesellschaft (ÖAG)
  15. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
  16. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
  17. Diabetes und Schwangerschaft
  18. The role of sex differences in cardiovascular, metabolic, and immune functions in health and disease: a review for “Sex Differences in Health Awareness Day”
  19. Assessment of fetal hepatic lipid content by magnetic resonance imaging and association of results with clinical maternal and fetal parameters
  20. Bariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota
  21. Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alström Syndrome, a Rare Obesity Syndrome
  22. Gestational Diabetes Mellitus (GDM), Diagnostics, Therapy and Follow-up Care
  23. A direct effect of the hematocrit on blood glucose: Evidence from hypoxia- and erythropoietin-treated mice
  24. Health Status and Patients’ Satisfaction on the Long Term after Metabolic/Bariatric Surgery
  25. Growth Hormone Promotes Hepatic Triglyceride Export in Humans
  26. Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings
  27. Gender-affirming hormone therapy and its impact on myocardial mass and cardiac function: a prospective magnetic resonance cohort study on transgender men and women
  28. Comparing Bioelectrical Impedance Analysis, Air Displacement Plethysmography, and Dual-Energy X-Ray Absorptiometry for Body Composition in Pediatric Obesity
  29. The effects of gender-affirming hormone therapy on myocardial, hepatic, pancreatic lipid content, body fat distribution and other cardiometabolic risk factors: A magnetic resonance-based study in transgender individuals
  30. Vascular strain of the aorta and peripheral arteries in patients with type 1 diabetes mellitus in comparison with healthy controls
  31. Assessing the relationship between sex, gender, and hypertension: A federated analysis of European and Canadian Public Health Surveys
  32. Incidence of Prediabetes and Diabetes in a European Longitudinal General Population Cohort and Its Associated Factors—Results From the Austrian LEAD Study
  33. What all physicians should know about women’s health: a Delphi study
  34. Association Between Glycemia, Glycemic Variability, and Pregnancy Complications in Early GDM
  35. Postpartum dysglycaemia after early gestational diabetes: Follow-up of women in the TOBOGM randomised controlled trial
  36. Sex differences in ectopic lipid deposits and cardiac function across a wide range of glycemic control: a secondary analysis
  37. Performance of LDL-C only compared to the Dutch Lipid Clinic Network Score for screening of familial hypercholesterolaemia: the Austrian experience and literature review
  38. Diabetes und Schwangerschaft
  39. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  40. Monitoring what matters to people with diabetes: Do we underestimate the importance of behaviour, attitude, and well-being?
  41. Sex, gender, and stroke recovery: Functional limitations and inpatient care needs in Canadian and European survivors
  42. Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT)
  43. Socioeconomic Gender Variables Impact the Association between Hypertension and Chronic Health Issues: Cross-Sectional Study
  44. Effect of treatment for early gestational diabetes mellitus on neonatal respiratory distress: A secondary analysis of the TOBOGM study
  45. Investigating a New Way to Assess Metabolic Risk in Pregnant Females with Prior RYGB Surgery
  46. PCSK9 inhibitors in real life—Cardiometabolic risk management in dyslipidemic patients in Vienna
  47. The Effects of Caloric Restriction and Clinical Psychological Intervention on the Interplay of Gut Microbial Composition and Stress in Women
  48. Sex differences in the diagnostic algorithm of screening for heart failure by symptoms and NT-proBNP in patients with type 2 diabetes
  49. Relationship Between Early-Pregnancy Glycemia and Adverse Outcomes: Findings From the TOBOGM Study
  50. The impact of the SARS-CoV2 pandemic on the prescription of thyroid medication in Austria – A nationwide population-based registry analysis
  51. 202-OR: Prediction of Late Gestational Diabetes Mellitus in Those without Early GDM
  52. 258-OR: The Effect of Early Initiation of Treatment on Glycemia and Pregnancy Outcomes in Women with Early Gestational Diabetes Mellitus
  53. Poor adherence during adolescence is a risk factor for becoming lost-to-follow-up in patients with phenylketonuria
  54. Association of prediabetes with clinical outcomes in patients with chronic coronary syndrome: a post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials
  55. Cost-effectiveness of diagnosis and treatment of early gestational diabetes mellitus: economic evaluation of the TOBOGM study, an international multicenter randomized controlled trial
  56. Diabetes und Schwangerschaft
  57. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  58. Sex differences of post-Covid patients undergoing outpatient pulmonary rehabilitation
  59. Typ-2-Diabetes: Auch das Geschlecht berücksichtigen
  60. Regression From Early GDM to Normal Glucose Tolerance and Adverse Pregnancy Outcomes in the Treatment of Booking Gestational Diabetes Mellitus Study
  61. Unraveling cradle-to-grave disease trajectories from multilayer comorbidity networks
  62. Association Between Immediate Treatment of Early Gestational Diabetes Mellitus and Breastfeeding Outcomes: Findings From the TOBOGM Study
  63. Role of sex and gender-related variables in development of metabolic syndrome: A prospective cohort study
  64. Female Patients Show a Larger Reduction in Suicidal Ideation in Inpatient Addiction Treatment Than Male Patients: Results of a Single-Center Observational Study
  65. Correlation between skeletal muscle acetylcarnitine and phosphocreatine metabolism during submaximal exercise and recovery: interleaved 1H/31P MRS 7 T study
  66. Profiling endogenous adrenal function during veno-venous ECMO support in COVID-19 ARDS: a descriptive analysis
  67. Gpcpd1–GPC metabolic pathway is dysfunctional in aging and its deficiency severely perturbs glucose metabolism
  68. International consensus on post-transplantation diabetes mellitus
  69. Putting person-centred psychosocial diabetes care into practice: two psychosocial care pathways based on outcome preferences of people with diabetes and healthcare professionals
  70. Linee guida ESC 2023 per il trattamento delle malattie cardiovascolari nei pazienti diabetici
  71. Standardising personalised diabetes care across European health settings: A person‐centred outcome set agreed in a multinational Delphi study
  72. Tracking chronic diseases via mobile health applications: Which user experience aspects are key? (Preprint)
  73. Which diabetes specific patient reported outcomes should be measured in routine care? A systematic review to inform a core outcome set for adults with Type 1 and 2 diabetes mellitus: The European Health Outcomes Observatory (H2O) programme
  74. Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure
  75. Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy
  76. Diabetes und Schwangerschaft
  77. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008)
  78. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
  79. Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status
  80. A comparison of synthetic data generation and federated analysis for enabling international evaluations of cardiovascular health
  81. Diabetes incidence in Austria: The role of famines on diabetes and related NCDs
  82. The relationship between body mass index and sleep in women with risk factors for gestational diabetes mellitus
  83. Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy
  84. Trends in diabetes incidence in Austria 2013–2017
  85. The Interplay of Adipokines, Body Composition and Glucose Homeostasis in Pregnant Women with a History of RYGB Operation
  86. Age and Sex Determine Electrocardiogram Parameters in the Octodon degus
  87. Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus
  88. Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
  89. Correction to: Sex differences in type 2 diabetes
  90. Systematic population-wide ecological analysis of regional variability in disease prevalence
  91. Magnesium in Kidney Function and Disease—Implications for Aging and Sex—A Narrative Review
  92. Sex differences in type 2 diabetes
  93. Sex and gender aspects in diabetes mellitus: Focus on access to health care and cardiovascular outcomes
  94. Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies
  95. Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial
  96. Diabetes and Pregnancy
  97. Gestational Diabetes Mellitus (GDM), Diagnostics, Therapy and Follow-up Care
  98. Geschlechtsspezifische Aspekte bei Prädiabetes und Diabetes mellitus – klinische Empfehlungen (Update 2023)
  99. Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2023)
  100. Diabetestechnologie (Update 2023)
  101. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2023)
  102. Gravidität bei vorbestehendem Diabetes (Update 2023)
  103. Diabetische Nierenerkrankung (Update 2023)
  104. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  105. Gestationsdiabetes (GDM) (Update 2023)
  106. Injektionstherapie (GLP1-Rezeptor Agonisten und Insulin) bei Typ 2 Diabetes mellitus (Update 2023)
  107. Psychische und neurokognitive Erkrankungen und Diabetes mellitus (Update 2023)
  108. Ernährungsempfehlungen für Menschen mit Diabetes (Update 2023)
  109. Diabetes und Schwangerschaft
  110. Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial
  111. Diabetes mellitus is associated with a higher relative risk for venous thromboembolism in females than in males
  112. The Timing of Pregnancies After Bariatric Surgery has No Impact on Children’s Health—a Nationwide Population-based Registry Analysis
  113. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study
  114. Leptin increases hepatic triglyceride export via a vagal mechanism in humans
  115. Sex and Gender Impact Mental and Emotional Well-Being During COVID-19 Pandemic: A European Countries Experience
  116. Effects of gender-affirming hormone therapy on cardiovascular risk factors focusing on glucose metabolism in an Austrian transgender cohort
  117. Diabetes und Schwangerschaft
  118. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008)
  119. Need for improving immunization status and preventive care in diabetes mellitus patients
  120. Vitamin D3 Supplementation in Overweight/Obese Pregnant Women: No Effects on the Maternal or Fetal Lipid Profile and Body Fat Distribution—A Secondary Analysis of the Multicentric, Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes...
  121. The Weak Relationship between Vitamin D Compounds and Glucose Homeostasis Measures in Pregnant Women with Obesity: An Exploratory Sub-Analysis of the DALI Study
  122. Gender dimension in cardio-pulmonary continuum
  123. Stress-testing the resilience of the Austrian healthcare system using agent-based simulation
  124. Nahrungsergänzungsmittel und die Schilddrüse – ein Update zur Supplementierung von Mikronährstoffen
  125. Biomarkers Predictive for In-Hospital Mortality in Patients with Diabetes Mellitus and Prediabetes Hospitalized for COVID-19 in Austria: An Analysis of COVID-19 in Diabetes Registry
  126. Awareness of sex and gender dimensions among physicians: the European federation of internal medicine assessment of gender differences in Europe (EFIM-IMAGINE) survey
  127. HbA1c and Glucose Management Indicator Discordance Associated with Obesity and Type 2 Diabetes in Intermittent Scanning Glucose Monitoring System
  128. Evaluation of a bariatric monitoring pass for primary care physicians
  129. Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease
  130. Authors’ Reply to: Using Caution When Interpreting Gender-Based Relative Risk. Comment on “The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis”
  131. Sex Differences in Clinical Characteristics and Outcomes of Patients with SARS-CoV-2-Infection Admitted to Intensive Care Units in Austria
  132. Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
  133. Deciphering metformin action in obese mice: A critical re-evaluation of established protocols
  134. Cardiovascular health through a sex and gender lens in six South Asian countries: Findings from the WHO STEPS surveillance
  135. Unraveling the Factors Determining Development of Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus Through Machine-Learning Techniques
  136. Authors’ Reply to: Using Caution When Interpreting Gender-Based Relative Risk. Comment on “The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis” (Preprint)
  137. Sex and Gender Influence on Cardiovascular Health in Sub-Saharan Africa: Findings from Ghana, Gambia, Mali, Guinea, and Botswana
  138. Diabetes und Schwangerschaft
  139. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  140. Glypican-4 in pregnancy and its relation to glucose metabolism, insulin resistance and gestational diabetes mellitus status
  141. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
  142. COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age—Propensity Score-Matched Analysis of Austrian National Public Health Institute Data
  143. Adipocyte STAT5 deficiency does not affect blood glucose homeostasis in obese mice
  144. Women With Cerebral Infarction Feature Worse Clinical Profiles at Admission but Comparable Success to Men During Long-Term Inpatient Neurorehabilitation
  145. Sex-Specific Differences in Mortality of Patients with a History of Bariatric Surgery: a Nation-Wide Population-Based Study
  146. Does diabetes mellitus mitigate the gender gap in COVID-19 mortality?
  147. The unexplored role of sedentary time and physical activity in glucose and lipid metabolism‐related placental mRNAs in pregnant women who are obese: the DALI lifestyle randomised controlled trial
  148. Model-Based Assessment of Hepatic and Extrahepatic Insulin Clearance from Short Insulin-Modified IVGTT in Women with a History of Gestational Diabetes
  149. Short Term Caloric Restriction and Biofeedback Enhance Psychological Wellbeing and Reduce Overweight in Healthy Women
  150. Glucose intolerance in aging is mediated by the Gpcpd1-GPC metabolic axis
  151. Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity
  152. Sex-Specific Effects of Vitamin D Status on the Metabolic Profile in Prediabetic Subjects
  153. The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis
  154. Characterization of endogenous bile acid composition in individuals with cold-activated brown adipose tissue
  155. Diabetes und Schwangerschaft
  156. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008)
  157. Insulin as Monotherapy and in Combination with Other Glucose-Lowering Drugs Is Related to Increased Risk of Diagnosis of Pneumonia: A Longitudinal Assessment over Two Years
  158. Sex, rurality and socioeconomical status in Spanish centennial population (2017)
  159. Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality
  160. Sex differences in brown adipose tissue activity and cold-induced thermogenesis
  161. Determinants of perceived health and unmet healthcare needs in universal healthcare systems with high gender equality
  162. Increase in testosterone levels is related to a lower risk of conversion of prediabetes to manifest diabetes in prediabetic males
  163. Data-driven identification of complex disease phenotypes
  164. Project “Backtoclinic I”: An overview on the state of care of adult PKU patients in Austria
  165. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  166. Diabetes und Schwangerschaft
  167. Combined hormonal contraceptives are associated with minor changes in composition and diversity in gut microbiota of healthy women
  168. Diagnostic Role of PET/CT Tracers in the Detection and Localization of Tumours Responsible for Ectopic Cushing’s Syndrome
  169. Risk of Typical Diabetes-Associated Complications in Different Clusters of Diabetic Patients: Analysis of Nine Risk Factors
  170. Diabetes Mellitus is Associated with a Higher Relative Risk for Parkinson’s Disease in Women than in Men
  171. Comparison of Bioelectrical Impedance-Based Methods on Body Composition in Young Patients with Obesity
  172. Iron Deficiency – Not Only a Premenopausal Topic After Bariatric Surgery?
  173. Sex-Related Differences in Drugs with Anti-Inflammatory Properties
  174. Sex- and Gender-Based Pharmacological Response to Drugs
  175. Identification and inclusion of gender factors in retrospective cohort studies: the GOING-FWD framework
  176. Gestational Diabetes Mellitus (GDM), Diagnostics, Therapy and Follow-up Care
  177. The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis (Preprint)
  178. Major Depressive Disorder (MDD) and Antidepressant Medication Are Overrepresented in High-Dose Statin Treatment
  179. Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with t...
  180. Acute and Life-threatening Complications in Cushing Syndrome: Prevalence, Predictors, and Mortality
  181. Biological and Psychological Stress Correlates Are Linked to Glucose Metabolism, Obesity, and Gender Roles in Women
  182. Diabetes and Pregnancy
  183. Decompression of Multimorbidity Along the Disease Trajectories of Diabetes Mellitus Patients
  184. Oral Contraceptive Intake and Iodine Status in Young Women
  185. Methods for prospectively incorporating gender into health sciences research
  186. RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy
  187. Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT-2 Inhibition
  188. Precision Medicine for the Management of Therapy Refractory Colorectal Cancer
  189. COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
  190. Intact vitamin A transport is critical for cold-mediated adipose tissue browning and thermogenesis
  191. Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers
  192. HbA1c during early pregnancy reflects beta-cell dysfunction in women developing GDM
  193. Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI
  194. CTRP-1 levels are related to insulin resistance in pregnancy and gestational diabetes mellitus
  195. Metabolic phenotypes of early gestational diabetes mellitus and their association with adverse pregnancy outcomes
  196. Do Women with Diabetes Need More Intensive Action for Cardiovascular Reduction than Men with Diabetes?
  197. Performance of early pregnancy HbA1c for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women
  198. Diabetes und Schwangerschaft
  199. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Praxisempfehlung – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008)
  200. Measurements of Plasma-Free Metanephrines by Immunoassay Versus Urinary Metanephrines and Catecholamines by Liquid Chromatography with Amperometric Detection for the Diagnosis of Pheochromocytoma/Paraganglioma
  201. Effects of Thyroid Function on Phosphodiester Concentrations in Skeletal Muscle and Liver: An In Vivo NMRS Study
  202. How Specialist Aftercare Impacts Long-Term Readmission Risks in Elderly Patients With Metabolic, Cardiac, and Chronic Obstructive Pulmonary Diseases: Cohort Study Using Administrative Data
  203. Metabolic syndrome and visceral adipose tissue (VAT) are associated with obstructive and restrictive lung function impairment
  204. The influence of sex and gender domains on COVID-19 cases and mortality
  205. Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men
  206. Sex-specific trends in smoking prevalence over seven years in different Austrian populations: results of a time-series cross-sectional analysis
  207. Betatrophin is downregulated in pregnant women with a history of RYGB operation and a high risk of postprandial hypoglycaemia
  208. Muscle‐Specific Relation of Acetylcarnitine and Intramyocellular Lipids to Chronic Hyperglycemia: A Pilot 3‐T 1H MRS Study
  209. Secretagogin is Related to Insulin Secretion but Unrelated to Gestational Diabetes Mellitus Status in Pregnancy
  210. Less sedentary time is associated with a more favourable glucose-insulin axis in obese pregnant women—a secondary analysis of the DALI study
  211. Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel
  212. Insulin clearance is altered in women with a history of gestational diabetes progressing to type 2 diabetes
  213. Pre-operative Obesity-Associated Hyperandrogenemia in Women and Hypogonadism in Men Have No Impact on Weight Loss Following Bariatric Surgery
  214. Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case–control study
  215. Psychopharmacological Medication Has No Influence on Vitamin Status After Bariatric Surgery in Long-term Follow-up
  216. Diabetes und Schwangerschaft
  217. Versorgung von Kindern und Jugendlichen mit Diabetes an Österreichs Schulen
  218. Sublingual microvasculature in diabetic patients
  219. The importance of maternal insulin resistance throughout pregnancy on neonatal adiposity
  220. The Presence of Active Brown Adipose Tissue Determines Cold-Induced Energy Expenditure and Oxylipin Profiles in Humans
  221. Identification and Potential Clinical Utility of the MTNR1B rs10830963 Core Gene Variant Associated to Endophenotypes in Gestational Diabetes Mellitus
  222. Assessing the quality of life among patients with diabetes in Austria and the correlation between glycemic control and the quality of life
  223. Increased ATP synthesis might counteract hepatic lipid accumulation in acromegaly
  224. High-risk multimorbidity patterns on the road to cardiovascular mortality
  225. Temporal relationships between maternal metabolic parameters with neonatal adiposity in women with obesity differ by neonatal sex: Secondary analysis of the DALI study
  226. Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using 18F-FDG PET/MRI
  227. The DALI vitamin D randomized controlled trial for gestational diabetes mellitus prevention: No major benefit shown besides vitamin D sufficiency
  228. Marked differences in prediabetes‐ and diabetes‐associated comorbidities between men and women—Epidemiological results from a general population‐based cohort aged 6‐80 years—The LEAD (Lung, hEart, sociAl, boDy) study
  229. Cold-mediated regulation of systemic retinol transport controls adipose tissue browning
  230. How Specialist Aftercare Impacts Long-Term Readmission Risks in Elderly Patients With Metabolic, Cardiac, and Chronic Obstructive Pulmonary Diseases: Cohort Study Using Administrative Data (Preprint)
  231. Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects
  232. Comments on: A functional polymorphism rs10830963 in melatonin receptor 1B associated with the risk of gestational diabetes mellitus
  233. Bariatric Surgery Impacts Levels of Serum Lipids during Pregnancy
  234. Former gestational diabetes: Mathematical modeling of intravenous glucose tolerance test for the assessment of insulin clearance and its determinants
  235. Glucose Effectiveness from Short Insulin-Modified IVGTT and Its Application to the Study of Women with Previous Gestational Diabetes Mellitus
  236. Sex-Related Differences in Pharmacokinetics and Pharmacodynamics of Frequently Prescribed Drugs: A Review of the Literature
  237. Relationship between psychological stress and metabolism in morbidly obese individuals
  238. Response to: ‘Association between osteoporosis and statin therapy: the story continues’ by Burden and Weiler
  239. Versorgung von Kindern und Jugendlichen mit Diabetes an Österreichs Schulen
  240. The Effects of Lifestyle and/or Vitamin D Supplementation Interventions on Pregnancy Outcomes: What Have We Learned from the DALI Studies?
  241. Assessing the health-related quality of life in type 2 diabetes patients treated with insulin and oral antidiabetic agents
  242. Evidence that the multiflorine‐derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α 2 ‐adrenoceptors in mice
  243. Österreichischer Blutdruckkonsens 2019
  244. Response to: ‘The association between osteoporosis and statins therapy’ by Lai
  245. Diabetes und Schwangerschaft
  246. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge – Praxisempfehlung – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-008)
  247. Diagnosis of osteoporosis in statin-treated patients is dose-dependent
  248. Insulin Clearance in Women with a History of Gestational Diabetes Assessed by Mathematical Model Analyses of Intravenous Glucose Tolerance Test
  249. Model-Based Assessment of Sex Differences in Glucose Effectiveness and Its Components
  250. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia
  251. Identifying a disease-specific renin–angiotensin–aldosterone system fingerprint in patients with primary adrenal insufficiency
  252. Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the Euro...
  253. Plasma renin levels are associated with cardiac function in primary adrenal insufficiency
  254. Diabetes und Schwangerschaft
  255. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  256. Diagnose und Management der Osteoporose bei Diabetes mellitus (Update 2019)
  257. Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen (Update 2019)
  258. Psychische Erkrankungen und Diabetes mellitus (Update 2019)
  259. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019)
  260. Gravidität bei vorbestehendem Diabetes (Update 2019)
  261. Diabetische Nierenerkrankung (Update 2019)
  262. Diagnostik und Therapie des Typ 1 Diabetes mellitus (Update 2019)
  263. Gestationsdiabetes (GDM) (Update 2019)
  264. Insulintherapie bei Typ 2 Diabetes mellitus (Update 2019)
  265. Ernährungsempfehlungen bei Diabetes mellitus (Update 2019)
  266. Geschlechtsspezifische Aspekte bei Prädiabetes und Diabetes mellitus – klinische Empfehlungen (Update 2019)
  267. Zusammenfassung der Überarbeitungen 2019
  268. Glucose effectiveness and its components in relation to body mass index
  269. A reduction in sedentary behaviour in obese women during pregnancy reduces neonatal adiposity: the DALI randomised controlled trial
  270. A Sex-Specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention
  271. Markedly Delayed Insulin Secretion and a High Rate of Undetected Overt Diabetes Characterize Glucose Metabolism in Adult Patients with Cystic Fibrosis After Lung Transplantation
  272. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation
  273. Mediators of Lifestyle Behaviour Changes in Obese Pregnant Women. Secondary Analyses from the DALI Lifestyle Randomised Controlled Trial
  274. Decreased beta-cell function in breastfeeding obese and non-obese women: A prospective observational study
  275. Gestational Diabetes Mellitus (GDM) – Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018)
  276. Sex- and age-related differences of metabolic parameters in impaired glucose metabolism and type 2 diabetes compared to normal glucose tolerance
  277. The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus
  278. Sex-specific analysis of haemodialysis prevalence, practices and mortality over time: the Austrian Dialysis Registry from 1965 to 2014
  279. The wave of sweetness and obesity continues
  280. Association between Gestational Weight Gain, Gestational Diabetes Risk, and Obstetric Outcomes: A Randomized Controlled Trial Post Hoc Analysis
  281. Diabetes und Schwangerschaft
  282. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  283. Pericardial Fat Relates to Disturbances of Glucose Metabolism in Women with the Polycystic Ovary Syndrome, but Not in Healthy Control Subjects
  284. Job-related meaningfulness moderates the association between over-commitment and emotional exhaustion in nurses
  285. Adiponectin and Leptin at Early Pregnancy: Association to Actual Glucose Disposal and Risk for GDM—A Prospective Cohort Study
  286. Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point
  287. Needle beats pill in gestational diabetes mellitus
  288. Assessment of glucose effectiveness from short IVGTT in individuals with different degrees of glucose tolerance
  289. Re: Vitamin D and gestational diabetes mellitus: a systematic review based on data free of Hawthorne effect
  290. Management of Pregnant Women after Bariatric Surgery
  291. Sex and Gender Differences in Prevention of Type 2 Diabetes
  292. Cost-effectiveness of healthy eating and/or physical activity promotion in pregnant women at increased risk of gestational diabetes mellitus: economic evaluation alongside the DALI study, a European multicenter randomized controlled trial
  293. Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes
  294. Diabetes in pregnancy: a new decade of challenges ahead
  295. Combined Metabolomic Analysis of Plasma and Urine Reveals AHBA, Tryptophan and Serotonin Metabolism as Potential Risk Factors in Gestational Diabetes Mellitus (GDM)
  296. Correlates of poor mental health in early pregnancy in obese European women
  297. Diabetes und Schwangerschaft
  298. Gestationsdiabetes mellitus (GDM) –Diagnostik, Therapie und Nachsorge , ,
  299. Assessment of glucose regulation in pregnancy after gastric bypass surgery
  300. Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients
  301. Is a motivational interviewing based lifestyle intervention for obese pregnant women across Europe implemented as planned? Process evaluation of the DALI study
  302. Sex and gender differences in therapy of type 2 diabetes
  303. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy
  304. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults
  305. Influence of gender, working field and psychosocial factors on the vulnerability for burnout in mental hospital staff: results of an Austrian cross-sectional study
  306. Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
  307. Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe
  308. Mann oder Frau: Ist das bei Diabetes relevant?
  309. The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients
  310. Similarities in trabecular hypertrophy with site-specific differences in cortical morphology between men and women with type 2 diabetes mellitus
  311. Diabetes und Schwangerschaft
  312. Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention
  313. Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients
  314. Microvascular function in women with former gestational diabetes: A cohort study
  315. Association Study with 77 SNPs Confirms the Robust Role for the rs10830963/G of MTNR1B Variant and Identifies Two Novel Associations in Gestational Diabetes Mellitus Development
  316. Type 2 Diabetes and Cardiovascular Risk in Women 2016
  317. Effect of physical activity and/or healthy eating on GDM risk: The DALI Lifestyle Study
  318. Increased Proportion of Hematopoietic Stem and Progenitor Cell Population in Cord Blood of Neonates Born to Mothers with Gestational Diabetes Mellitus
  319. Better insight into gender-specific diabetes self-management for more effective diabetes services
  320. Use of statins offsets insulin-related cancer risk
  321. Gestationsdiabetes mellitus (GDM) –Diagnostik, Therapie und Nachsorge ,
  322. Diabetes und Schwangerschaft
  323. Altered glucose profiles and risk for hypoglycaemia during oral glucose tolerance testing in pregnancies after gastric bypass surgery
  324. Wie Gender in die Diabetes-Selbstmanagement-Applikation kommt – ein vielversprechender Weg
  325. Diabetes und Schwangerschaft
  326. To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS
  327. The impact of preconceptional obesity on trajectories of maternal lipids during gestation
  328. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
  329. IADPSG and WHO 2013 Gestational Diabetes Mellitus Criteria Identify Obese Women With Marked Insulin Resistance in Early Pregnancy: Table 1
  330. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study
  331. Migration und Diabetes
  332. Psychische Erkrankungen und Diabetes mellitus
  333. Insulintherapie bei Diabetes mellitus
  334. Geschlechtsspezifische Aspekte für die klinische Praxis bei Prädiabetes und Diabetes mellitus
  335. Gestationsdiabetes (GDM)
  336. Gravidität bei vorbestehendem Diabetes für die Leitlinien für die Praxis (AG Diabetes und Schwangerschaft der ÖDG)
  337. Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen
  338. Diabetische Nierenerkrankung – Update 2016
  339. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2
  340. Initial evidence for the link between activities and health: Associations between a balance of activities, functioning and serum levels of cytokines and C-reactive protein
  341. Brennpunkt Adipositas: what gender has to do with …!
  342. Sexualität bei Übergewicht und Adipositas
  343. Clinical and metabolic characteristics of treated hyperlipidemic patients additionally affected by subclinical hyperglycemia
  344. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
  345. Diabetes mellitus und Schwangerschaft
  346. The Cross-Link between Adipokines, Insulin Resistance and Obesity in Offspring of Diabetic Pregnancies
  347. Cardiometabolic Risk in Hyperlipidemic Men and Women
  348. Beliefs, Barriers, and Preferences of European Overweight Women to Adopt a Healthier Lifestyle in Pregnancy to Minimize Risk of Developing Gestational Diabetes Mellitus: An Explorative Study
  349. Gender Obesity Report – Einfluss von Adipositas auf Reproduktion und Schwangerschaft
  350. Human insulin dynamics in women: a physiologically based model
  351. Gender Awareness bei Medizinstudierenden der Medizinischen Universität Wien. Eine empirische Analyse von Geschlechtersensibilität und Geschlechterstereotypisierungen
  352. Application of Penalized Regression Techniques in Modelling Insulin Sensitivity by Correlated Metabolic Parameters
  353. Gender and heart disease
  354. Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus
  355. Potential of a Sports Club–Based Exercise Program for Improving Physical Activity in Type 2 Diabetes Mellitus
  356. Lactation and appetite-regulating hormones: increased maternal plasma peptide YY concentrations 3–6 months postpartum
  357. Physical activity, depressed mood and pregnancy worries in European obese pregnant women: results from the DALI study
  358. Results From a European Multicenter Randomized Trial of Physical Activity and/or Healthy Eating to Reduce the Risk of Gestational Diabetes Mellitus: The DALI Lifestyle Pilot
  359. Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation
  360. Diabetes in pregnancy outcomes: A systematic review and proposed codification of definitions
  361. To explain the variation of OGTT dynamics by biological mechanisms: a novel approach based on principal components analysis in women with history of GDM
  362. Quantification of Diabetes Comorbidity Risks across Life Using Nation-Wide Big Claims Data
  363. Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials
  364. Pathophysiological Characteristics and Effects of Obesity in Women With Early and Late Manifestation of Gestational Diabetes Diagnosed by the International Association of Diabetes and Pregnancy Study Groups Criteria
  365. Contrast induced acute kidney injury in acute coronary syndrome patients: A single centre experience
  366. Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference
  367. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes
  368. Diabetes und Schwangerschaft
  369. Diabetes mellitus und Schwangerschaft
  370. Type 2 Diabetes and Cardiovascular Risk in Women
  371. Hidden Metabolic Disturbances in Women with Normal Glucose Tolerance Five Years after Gestational Diabetes
  372. Definitions of occupational balance and their coverage by instruments
  373. Iodine deficiency in pregnant women in Austria
  374. Sex-specific differences in diabetes prevention: a systematic review and meta-analysis
  375. No Evidence of Ectopic Lipid Accumulation in the Pathophysiology of the Acromegalic Cardiomyopathy
  376. CN-06 * IS HYPOPITUITARISM CLINICALLY RELEVANT IN GLIOMA PATIENTS? - A CROSS-SELECTIONAL TRIAL IN PATIENTS WITH HIGH-GRADE GLIOMAS
  377. Sex-Specific Differences in Hemodialysis Prevalence and Practices and the Male-to-Female Mortality Rate: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
  378. Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus
  379. Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
  380. Gendermedizin
  381. Gestational Diabetes Mellitus (GDM) Diagnosis, Therapy and Follow-Up Care
  382. Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
  383. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus?
  384. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals
  385. Hepatic Rather Than Cardiac Steatosis Relates to Glucose Intolerance in Women with Prior Gestational Diabetes
  386. Predicting the Metabolic Condition After Gestational Diabetes Mellitus from Oral Glucose Tolerance Test Curves Shape
  387. Diabetes in Hyperparathyroidism
  388. Gestational diabetes mellitus and cardiovascular risk after pregnancy
  389. Effect of Fetal and Infant Malnutrition on Metabolism in Older Age
  390. Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing
  391. Typ-1-Diabetes
  392. Development of a new occupational balance-questionnaire: incorporating the perspectives of patients and healthy people in the design of a self-reported occupational balance outcome instrument
  393. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma
  394. Diabetologie kompakt
  395. Diabetes und Schwangerschaft
  396. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer
  397. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer
  398. Lower Fasting Muscle Mitochondrial Activity Relates to Hepatic Steatosis in Humans
  399. Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy
  400. DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial – study protocol
  401. Analysis of Intravenous Glucose Tolerance Test Data Using Parametric and Nonparametric Modeling: Application to a Population at Risk for Diabetes
  402. Geschlechtsspezifische Unterschiede der Endokrinologie im Alter
  403. Reply to Klitz and Niklasson: Can viral infections explain the cross-sectional Austrian diabetes data?
  404. Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century
  405. Relationship of pentraxin 3 with insulin sensitivity in gestational diabetes
  406. Nur „der kleine Unterschied“?
  407. Concentration of Free Amino Acids in Human Milk of Women with Gestational Diabetes Mellitus and Healthy Women
  408. Estimating the risk after gestational diabetes mellitus: can we improve the information from the postpartum OGTT?
  409. Lipoprotein(a) is not related to markers of insulin resistance in pregnancy
  410. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study
  411. The impact of recurrent gestational diabetes on maternal metabolic and cardiovascular risk factors
  412. Migration und Diabetes
  413. Positionspapier: Psychische Erkrankungen und Diabetes mellitus
  414. Insulintherapie bei Diabetes mellitus
  415. Geschlechtsspezifische Aspekte für die klinische Praxis bei Prädiabetes und Diabetes mellitus
  416. Gravidität bei vorbestehendem Diabetes für die Leitlinien für die Praxis (AG Diabetes und Schwangerschaft der ÖDG)
  417. Gestationsdiabetes (GDM)
  418. Leitlinien Insulinpumpentherapie bei Kindern und Erwachsenen (Für den Ausschuss Insulinpumpentherapie der Österreichischen Diabetesgesellschaft)
  419. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2
  420. Diabetische Nephropathie – Update 2012
  421. Retinal white blood cell flux and systemic blood pressure in patients with type 1 diabetes
  422. Progression to Type 2 Diabetes in Women with Former Gestational Diabetes: Time Trajectories of Metabolic Parameters
  423. Sex-specific differences in long-term glycemic control and cardiometabolic parameters in patients with type 1 diabetes treated at a tertiary care centre
  424. A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus
  425. Obesity and Diabetes
  426. Adrenal Disorders
  427. Thyroid Disorders
  428. Challenges of Work–Life Balance for Women Physicians/Mothers Working in Leadership Positions
  429. CTX (Crosslaps) Rather than Osteopontin Is Associated with Disturbed Glucose Metabolism in Gestational Diabetes
  430. Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus
  431. Circulating progranulin levels in women with gestational diabetes mellitus and healthy controls during and after pregnancy
  432. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review
  433. Associations of Body Mass Index (Maternal BMI) and Gestational Diabetes Mellitus with Neonatal and Maternal Pregnancy Outcomes in a Multicentre European Database (Diabetes and Pregnancy Vitamin D and Lifestyle Intervention for Gestational Diabetes Mel...
  434. Diabetic Polyneuropathy Relates to Bone Metabolism and Markers of Bone Turnover in Elderly Patients With Type 2 Diabetes: Greater Effects in Male Patients
  435. Women show a closer association between educational level and hypertension or diabetes mellitus than males: a secondary analysis from the Austrian HIS
  436. Evaluation of educational needs in patients with diabetes mellitus in respect of medication use in Austria
  437. Transcription factor 7-like 2 gene polymorphisms and gestational diabetes mellitus
  438. Levels of fetuin-A relate to the levels of bone turnover biomarkers in male and female patients with type 2 diabetes
  439. Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease
  440. Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models
  441. Fatty Liver Index Predicts Further Metabolic Deteriorations in Women with Previous Gestational Diabetes
  442. Non-esterified fatty acid dynamics during oral glucose tolerance test in women with former gestational diabetes
  443. Influence of Increasing BMI on Insulin Sensitivity and Secretion in Normotolerant Men and Women of a Wide Age Span
  444. Characterization of Former Gestational Diabetes Mellitus: Prognostic, Therapeutic, and Predictive Aspects
  445. The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome
  446. Fetuin-A Characteristics during and after Pregnancy: Result from a Case Control Pilot Study
  447. Incretin Effect in Women with Former Gestational Diabetes within a Short Period after Delivery
  448. Gestational Diabetes Prediction Score (GPS): Eine kosteneffektive Möglichkeit zur Vorhersage von Gestationsdiabetes bei Schwangerschaften mit normalem Nüchternblutzucker
  449. Sex and Gender Differences in Endocrinology
  450. Diabetes und Schwangerschaft
  451. Impact of diabetes mellitus and gender on exercise-related antiangiogenic endostatin/collagen XVIII release
  452. Influence of age, smoking and T2 diabetes on exercise related antiangiogenic endostatin/collagen XVIII release in men
  453. Diabetes und Schwangerschaft
  454. Gestationsdiabetes mellitus (GDM)
  455. Gestationsdiabetes mellitus (GDM) - Diagnostik, Therapie u. Nachsorge
  456. Admission Proinsulin Is Associated with Mortality in Patients with Admission Hyperglycemia during Acute Coronary Syndrome: Results from a Pilot Observational Study
  457. Skeletal Muscle Phosphodiester Content Relates to Body Mass and Glycemic Control
  458. Early Possible Risk Factors for Overt Diabetes After Gestational Diabetes Mellitus
  459. Recruitment of patients with type 2 diabetes for target group specific exercise programs at an Outpatient Department of a Medical University: A factor analysis
  460. Glucose Absorption in Gestational Diabetes Mellitus During an Oral Glucose Tolerance Test
  461. Insulin resistance is not associated with myocardial steatosis in women
  462. Relations of Adiponectin to Levels of Metabolic Parameters and Sexual Hormones in Elderly Type 2 Diabetic Patients
  463. Clinical characteristics, modalities and complications of diabetic patients with migration background at a Central European University Clinic
  464. Editorial: Sex- and gender-based medicine: a challenging field of research
  465. Health behaviour and attitude towards screening examinations in an Austrian urban and rural population: gender aspects – screening and sex
  466. Identification of a model of non-esterified fatty acids dynamics through genetic algorithms: The case of women with a history of gestational diabetes
  467. Perspectives on gender-specific medicine, course and learning style preferences in medical education: a study among students at the Medical University of Vienna
  468. Mechanism and Effects of Glucose Absorption during an Oral Glucose Tolerance Test Among Females and Males
  469. Risk Factor Profile and Pregnancy Outcome in Women with Type 1 and Type 2 Diabetes Mellitus
  470. Coverage of recommended vaccinations in subjects with diabetes mellitus and ischemic heart disease: results for women and men
  471. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance?
  472. Diabetes mellitus und Schwangerschaft
  473. N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
  474. Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study
  475. Plasma neuropeptide Y levels differ in distinct diabetic conditions
  476. Sex-Specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus
  477. Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus
  478. Body and Liver Fat Mass Rather Than Muscle Mitochondrial Function Determine Glucose Metabolism in Women With a History of Gestational Diabetes Mellitus
  479. Diabetes und Schwangerschaft
  480. Retinal Blood Flow in Type 1 Diabetic Patients With No or Mild Diabetic Retinopathy During Euglycemic Clamp
  481. Changes in Serum Lipid Levels During Pregnancy in Type 1 and Type 2 Diabetic Subjects
  482. Cross-sectional survey on thyroideal and gonadal hormones in adult patients with high-grade gliomas.
  483. Acht-wöchiges Bewegungsprogramm für Diabetiker verändert nachhaltig deren körperliche Aktivität
  484. Herzfunktion und myocardialer Lipidgehalt bei Frauen nach Gestationsdiabetes
  485. Science & gender: vision and mission
  486. Retinol-Binding Protein 4 in Patients with Gestational Diabetes Mellitus
  487. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
  488. Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus
  489. A Markov chain probability model of glucose tolerance in post gestational diabetes follow up study
  490. A Self-organizing map based morphological analysis of oral glucose tolerance test curves in women with gestational diabetes mellitus
  491. Diabetes mellitus – Leitlinien für die Praxis
  492. Osteocalcin Is Related to Enhanced Insulin Secretion in Gestational Diabetes Mellitus
  493. Metabolic diseases and associated complications: sex and gender matter!
  494. Serum Vaspin Concentrations in Relation to Insulin Sensitivity Following RYGB-Induced Weight Loss
  495. TCF7L2– Polymorphismen und Gestationsdiabetes
  496. Faktorenanalyse bei Patienten mit Diabetes mellitus, die den Teilnahmewunsch an einem medizinischen Trainingsprogramm beeinflussen
  497. Veränderungen der körperlichen Aktivität im 6 Monate Follow-up in Folge eines 8-wöchigen Bewegungsprogramms
  498. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH)
  499. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes
  500. Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance
  501. Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes
  502. The Impact of Risk Factors and More Stringent Diagnostic Criteria of Gestational Diabetes on Outcomes in Central European Women
  503. Retinol – bindendes Protein 4 bei Patientinnen mit Gestationsdiabetes
  504. Diabetes und Schwangerschaft
  505. Insulin resistance has no impact on ghrelin suppression in pregnancy
  506. Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes
  507. Diabetes mellitus – Leitlinien für die Praxis
  508. Diabetes und Schwangerschaft
  509. Visfatin Response to Glucose Is Reduced in Women With Gestational Diabetes Mellitus
  510. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus
  511. Improved usability of the minimal model of insulin sensitivity based on an automated approach and genetic algorithms for parameter estimation
  512. Impaired cardiac autonomic function in women with prior gestational diabetes mellitus
  513. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione
  514. Insulinogenic indices from insulin and C-peptide: Comparison of beta-cell function from OGTT and IVGTT
  515. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes
  516. Impaired beta-cell function in lean normotolerant former gestational diabetic women
  517. Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester
  518. Sind "Designer"-Insuline die "besseren" Insuline?
  519. Severe diabetic fetopathy despite strict metabolic control
  520. Large-for-gestational-age newborns in women with insulin-treated gestational diabetes under strict metabolic control
  521. Endocrine Changes in Diabetic Pregnancy
  522. Fetal Hyperinsulinism and Maternal One-Hour Postload Plasma Glucose Level
  523. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus
  524. Haptoglobin Phenotype and Gestational Diabetes
  525. 40th EASD Annual Meeting of the European Association for the Study of Diabetes
  526. Diabetes in der Schwangerschaft
  527. Diabetes in der Praxis
  528. Gestational Diabetes
  529. Mode of action of ipomoea batatas (caiapo) in type 2 diabetic patients
  530. Basal and dynamic proinsulin-insulin relationship to assess β-cell function during OGTT in metabolic disorders
  531. Diabetes-Screening in der Schwangerschaft
  532. Increased Intramyocellular Lipid Concentration Identifies Impaired Glucose Metabolism in Women With Previous Gestational Diabetes
  533. Circulating concentrations of asymmetrical dimethyl- L -arginine are increased in women with previous gestational diabetes
  534. Ocular hyperperfusion following onset of intensified insulin therapy is inversely correlated with plasma endothelin-1 in Type I diabetes
  535. Book reviews
  536. Increased plasma leptin in gestational diabetes
  537. The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy
  538. Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men
  539. 35th Annual Meeting of the European Association for the Study of Diabetes
  540. Elevation of plasma leptin concentrations in obese hyperinsulinaemic hypothyroidism before and after treatment
  541. Ectopic thyroid gland simulating a submandibular tumor
  542. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
  543. Persistent Elevation and Metabolic Dependence of Circulating E-Selectin after Delivery in Women with Gestational Diabetes Mellitus
  544. Persistent Elevation and Metabolic Dependence of Circulating E-Selectin after Delivery in Women with Gestational Diabetes Mellitus
  545. Pronounced Insulin Resistance and Inadequate  -cell Secretion Characterize Lean Gestational Diabetes During and After Pregnancy
  546. Amylin: History and Overview
  547. Amylin Release During Oral Glucose Tolerance Test
  548. Elevated Islet Amyloid Pancreatic Polypeptide and Proinsulin in Lean Gestational Diabetes
  549. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes
  550. β-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects
  551. Integrated mathematical model to assess beta-cell activity during the oral glucose test
  552. Intravenous calcitriol normalizes insulin sensitivity in uremic patients
  553. Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study
  554. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.
  555. Role of islet amyloid polypeptide secretion in insulin-resistant humans
  556. Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria
  557. Hormonal and blood glucose responsiveness as an indicator of specific emotional arousal in type 1 diabetics
  558. Elevated hepatic insulin extraction in essential hypertension
  559. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans
  560. Colour doppler imaging of partial subclavian steal syndrome
  561. β-Cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects
  562. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery
  563. Laboratory monitoring of thromboprophylaxis with low molecular weight and standard heparin
  564. Insulin Sensitivity, Secretion and Hepatic Extraction in Untreated Hypertensive Patients